Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Engineered extracellular vesicles efficiently deliver CRISPR-Cas9 ribonucleoprotein (RNP) to inhibit herpes simplex virus1 infection in vitro and in vivo

12 Oct 2023

Abstract excerpt

Extracellular vesicles (EVs) have recently emerged as a promising delivery platform for CRISPR/Cas9 ribonucleoproteins (RNPs), owing to their ability to minimize off-target effects and immune responses. However, enhancements are required to boost the efficiency and safety of Cas9 RNP enrichment within EVs. In response, we employed the Fc/Spa interaction system, in which the human Fc domain was fused to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Extracellular vesicles in disease
Share to Mosquito-borne diseases and control
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38486996
DOI: 10.1016/j.apsb.2023.10.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Engineered extracellular vesicles efficiently deliver CRISPR-Cas9 ribonucleoprotein (RNP) to inhibit herpes simplex virus1 infection in vitro and in vivoPMID 38486996Read ↗

Gene Editing by Extracellular Vesicles.Semantic proximity Read ↗

Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human CellsSemantic proximity Read ↗

VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9Semantic proximity Read ↗

A modular strategy for extracellular vesicle-mediated CRISPR-Cas9 delivery through aptamer-based loading and UV-activated cargo releaseSemantic proximity Read ↗

Nature Inspired Delivery Vehicles for CRISPR‐Based Genome EditingSemantic proximity Read ↗

Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV ProvirusSemantic proximity Read ↗

CRISPR delivery with extracellular vesicles: Promises and challengesSemantic proximity Read ↗

Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic FibrosisSemantic proximity Read ↗

Efficient genome editing in the non-human primate brain using programmable extracellular vesiclesSemantic proximity Read ↗

Diverse Populations of Extracellular Vesicles with Opposite Functions during Herpes Simplex Virus 1 InfectionSemantic proximity Read ↗

Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9Semantic proximity Read ↗

Generation of Cellular Biofactories for Scalable Production of Surface-Engineered Extracellular Vesicles via CRISPR Genome EditingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.